Sylics offers innovative research solutions for preclinical neuroscience. We specialize in developing and employing customized mouse models, and in behavioral tests to evaluate compound effects on and disease mechanisms of neurological and psychiatric diseases, with a strong focus on neurodegeneration (cognitive impairment, Alzheimer’s disease, Parkinson’s disease,  ALS) and Schizophrenia.

Highly efficient, sensitive and reproducible automated screening for behavioral deficits in mouse models is supported by our automated behavioral screening platform and proprietary analysis software AHCODA™. Raw tracking data is automatically processed, quality-checked and analyzed by our cloud-based analysis software. Within 24 hours, all relevant parameters are visualized on a private website, with publish-ready art and statistics.